Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma

Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

786 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 172
Recruiting: 93
Ph III recruiting: 9
Growth YoY: +32.4%
Industry share: 20%
Top sponsor: Ruijin Hospital
Termination share: 34.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (129)

clinicaltrialsPublishedShowing 101–150 of 400 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07276698	Clinical Study on Maintenance Therapy With Selinexor Combined With Azacitidine After Allogeneic Hematopoietic Stem Cell Transplantation for NK/T-cell Lymphoma	not yet recruiting	Phase 2	39	Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER	0	Dec 11, 2025	clinicaltrials
NCT07276737	Preconditioning With a Combination of Thiotepa, Cyclophosphamide, and Busulfan for Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of NK/T-Cell Lymphoma	not yet recruiting	Phase 2	37	Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine